HF 1257

  • Minnesota House Bill
  • 2019-2020 Regular Session
  • Introduced in House Feb 14, 2019
  • House
  • Senate
  • Governor

Prescription drug benefit transparency and disclosure required.

Votes


No votes to display

Actions


Mar 26, 2020

House

Committee report, without further recommendation re-refer to Ways and Means

Mar 11, 2020

House

Committee report, without further rec to amend, re-refer to State Government Finance Division

Feb 27, 2020

House

Division action, to adopt as amended and return to Ways and Means

House

Author added Bierman

Feb 26, 2020

House

Authors added Her and Hansen

Mar 20, 2019

House

Author added Mariani

Mar 18, 2019

House

Author added Hornstein

House

Committee report, to adopt and re-refer to Ways and Means

House

Referred by Chair to Health and Human Services Finance Division

Mar 13, 2019

House

Authors added Brand and Poston

Mar 11, 2019

House

Authors added Masin and Bahner

Mar 07, 2019

House

Author added Moller

Mar 04, 2019

House

Committee report, to adopt and re-refer to Health and Human Services Policy

Feb 27, 2019

House

Author added Freiberg

Feb 18, 2019

House

Author added Xiong, J.

Feb 14, 2019

House

Introduction and first reading, referred to Commerce

Bill Text

Bill Text Versions Format
Introduction HTML
1st Engrossment HTML
1st Division Engrossment HTML

Related Documents

Document Format
No related documents.

Sources

Data on Open States is updated periodically throughout the day from the official website of the Minnesota Legislature.

If you notice any inconsistencies with these official sources, feel free to file an issue.